2. Aubagio (Teriflunomide)
Aubagio (chemically known as teriflunomide) marketed by Sanofi, is an active metabolite of the compound leflunomide and is a pyrimidine synthesis inhibitor. It is an oral formulation that has immunomodulatory properties, and can mitigate the rate and extent of damage caused to nerve fibers in neurodegenerative conditions such as multiple sclerosis (MS).
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?